Clinical Performance and Stability of Different Types of Implant Supported Overdenture
NCT ID: NCT05972538
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2023-04-01
2023-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patients were divided into two groups according to the definitive prosthesis.
Group I received ball and socket retained mandibular implant overdenture while Group II received cement retained implant supported fixed bridges.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Satisfaction and Crestal Bone Changes Around One-piece Zirconia(Zr) and Titanium(Ti) in Implant-Retained Mandibular Overdenture
NCT06643975
Implant Retained Overdenture VERSUS Implant Canine Retained Overdenture.
NCT07046104
Patient's Satisfaction of Mandibular Implant Supported Overdentures With Reduced Denture Base Extensions.
NCT06850558
Outcome of Implant-supported Overdentures
NCT03777748
Dental Implant Stability Placed in Healed Bony Sites Using Oversized Drilling Versus Conventional Drilling Protocol
NCT06917638
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
patients received ball and socket retained mandibular implant overdentures restoring complete edentulous mandible.
Osstell ( Osstell AB, Goteborg, Sweden).
Implant stability were assessed on 15, 30,60 and 90 days of prosthesis delivery
periodontal probe (Vivacare, TPS, Vivadent, Schaan, Lichtenstein
Clinical evaluation included assessment of pocket depth, plaque index and bleeding on probing) around the implant abutments on 15, 30,60 and 90 days of prosthesis delivery
questionnaire for patient satisfaction
A questionnaire was used to evaluate patient satisfaction on 90 days at the end of follow up period.
Group II
patients received cement retained mandibular implant overdentures restoring complete edentulous mandible.
Osstell ( Osstell AB, Goteborg, Sweden).
Implant stability were assessed on 15, 30,60 and 90 days of prosthesis delivery
periodontal probe (Vivacare, TPS, Vivadent, Schaan, Lichtenstein
Clinical evaluation included assessment of pocket depth, plaque index and bleeding on probing) around the implant abutments on 15, 30,60 and 90 days of prosthesis delivery
questionnaire for patient satisfaction
A questionnaire was used to evaluate patient satisfaction on 90 days at the end of follow up period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Osstell ( Osstell AB, Goteborg, Sweden).
Implant stability were assessed on 15, 30,60 and 90 days of prosthesis delivery
periodontal probe (Vivacare, TPS, Vivadent, Schaan, Lichtenstein
Clinical evaluation included assessment of pocket depth, plaque index and bleeding on probing) around the implant abutments on 15, 30,60 and 90 days of prosthesis delivery
questionnaire for patient satisfaction
A questionnaire was used to evaluate patient satisfaction on 90 days at the end of follow up period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-smoker
* systemically free from any chronic diseases
Exclusion Criteria
* patients having knife edge, flat or flabby ridge,
* patients having T. M. J disorders
40 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Centre, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asmaa Nabil Elboraey
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Asmaa N. Elboraey, Asso, Prof
Role: PRINCIPAL_INVESTIGATOR
National Research Centre, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Research Centre
Cairo, Dokki, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
64312012023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.